Monash IVF's own review attributed a Brisbane and a Clayton embryo mix-up to human error, with IT system limitations named as a contributing factor in the Clayton incident — but a company-commissioned review does not decide any individual patient's civil claim.
If you had a partner embryo transfer at Monash IVF, the published findings now give you more specific questions to ask about identification, witnessing and your records.
On 20 August 2025, Monash IVF announced that the independent review it commissioned from Fiona McLeod AO SC had concluded. The company said the full report would not be released publicly to protect the affected patients' privacy.
The published summary covered two unrelated incidents:
| Incident | What the company confirmed | Review finding |
|---|---|---|
| Brisbane | One patient's embryo was transferred to another patient, resulting in the birth of a child. Monash IVF said it became aware of the incident in February 2025. | Human error |
| Clayton, 5 June 2025 | A patient received her own embryo instead of the embryo of her partner specified in the treatment plan. | Human error at multiple stages, together with IT system limitations in the specific circumstances of a partner embryo transfer |
The company said it had implemented additional safeguards and many of the review's recommendations.
There have been important developments since the review. Victoria's Health Regulator concluded its investigation into the Clayton incident in November 2025 and imposed conditions on Monash IVF's registration. Those conditions focus on traceability, consent and documentation, verification checks, accurate recording and staff capability.
Michael Knaap resigned as Monash IVF's chief executive and managing director effective 12 June 2025. The ASX notice records the timing of his resignation but does not say that the independent review caused it.
What is established — and what remains unknown?
| Established in the public record | Not established by the public record |
|---|---|
| Two separate embryo-transfer incidents occurred. | The full content of the McLeod review. |
| The Brisbane incident was attributed to human error. | Whether any other patients were affected. |
| The Clayton incident involved human error at multiple stages and IT limitations in a partner transfer. | Whether the same IT limitation existed at other clinics or in other systems. |
| The Victorian regulator completed its Clayton investigation and imposed registration conditions. | Civil liability or compensation for any individual patient. |
| Monash IVF said additional safeguards and protocols were implemented. | Whether any particular patient's records show an identification or witnessing failure. |
The distinction matters. The review was commissioned by Monash IVF. It is not a court judgment, and it does not determine any patient's civil claim. The Victorian regulator's enforcement action is also separate from deciding whether an individual patient is entitled to compensation.
Who should ask for records?
The published material does not identify a wider affected cohort. It does, however, give patients who had a partner embryo transfer a reason to understand what records exist and how their transfer was verified.
Useful records may include:
- the treatment plan and consent documents;
- embryology and transfer records;
- embryo identifiers and storage records;
- electronic or manual witnessing logs;
- dual sign-offs and patient-confirmation records;
- notes explaining any change to the planned embryo; and
- correspondence about an incident, discrepancy or internal review.
An incomplete record is not automatically proof of negligence or a systems failure. It may justify further questions, including what checks were required, what checks were recorded and whether the clinic can reconstruct the chain of identification.
You can read What can go wrong in IVF for a broader explanation of embryo-identification, witnessing and storage failures.
The earlier $56 million class action was about a different issue
The Monash IVF group proceeding concerned cell-free non-invasive pre-implantation genetic testing used between May 2019 and October 2020. It alleged that embryos were classified as abnormal after testing that carried an undisclosed risk of false-positive results.
Monash IVF announced in August 2024 that it had agreed to a $56 million settlement, subject to court approval. The Supreme Court approved the settlement in Bopping & Anor v Monash IVF Pty Ltd & Ors [2024] VSC 785. The settlement did not decide liability for the later Brisbane or Clayton embryo-transfer incidents.
That distinction is important. The group proceeding concerned genetic testing and the classification of embryos. The two later incidents concern embryo identification and transfer. A previous settlement involving the same provider does not prove negligence in a different treatment or incident.
What does a legal assessment still have to answer?
Even where an incident or systems limitation is acknowledged, an individual claim still depends on the person's circumstances and the applicable law.
A lawyer may need to consider:
- what treatment was planned and consented to;
- which embryo was transferred;
- what identification and witnessing process applied;
- whether the care fell below the legally required standard;
- whether any failure caused psychiatric injury, financial loss or other compensable harm;
- which state or territory's law applies; and
- whether the claim is within time.
A review finding or regulatory condition may be relevant evidence. It does not remove the need to prove the elements of a civil claim.
For a plain-English overview, see IVF and fertility clinic claims and time limits for IVF and fertility claims.
Why does Clever Legal look closely at these cases?
Embryo-transfer cases can involve records spread across treatment cycles, technical witnessing systems and difficult questions about causation and loss.
Our technology helps organise the records and build the chronology. Our lawyers review the evidence and make every legal decision.
We do not assume that a public incident means another patient has a claim. We look at the records and tell you plainly whether there is a reasonable next step. There is no guaranteed outcome.
Quick answers
Has the Monash IVF review been released?
No. Monash IVF's ASX announcement says the review is complete but will not be released publicly to protect patient privacy. Only a summary of findings has been published.
Is the Victorian regulator still investigating?
No. The Health Regulator announced in November 2025 that it had concluded its investigation into the Clayton incident and imposed conditions on Monash IVF's registration. It said it would continue monitoring compliance.
Was the IT limitation present at every Monash IVF clinic?
The public summary does not answer that question. It describes IT limitations in the specific circumstances of a partner embryo transfer. It does not identify a wider affected cohort or say whether the relevant system was shared across clinics.
Can I find out whether my embryo transfer was affected?
Request your complete embryology and transfer records and ask the clinic to explain the identification and witnessing steps used in your treatment. Any gap or discrepancy should be investigated, but it does not by itself establish negligence.
What if I signed a consent form?
A consent form records information and choices about treatment. It does not, by itself, answer whether the correct embryo was identified and transferred or whether reasonable care was taken. The legal effect depends on the facts and applicable law.
Is there a class action about these two mix-ups?
As at 23 August 2026, the official sources linked below do not identify a class action concerning the Brisbane and Clayton embryo-transfer incidents. That position can change. The earlier Monash IVF group proceeding concerned a different genetic-testing service.
Start your assessment
If you had a partner embryo transfer at a Monash IVF clinic and are concerned about embryo identification, transfer or genetic parentage, start a free assessment with Clever Legal.
Tell us the clinic and treatment dates, whether it was a partner embryo transfer, what you were told about the embryo transferred, any genetic testing performed, any discrepancy or unexpected outcome, and what records or earlier legal response you already have.
We can tell you whether the matter is within our Victorian practice and whether there is a reasonable next step. Medical negligence claims are subject to time limits, so seek specific advice promptly.
This article provides general information and is not legal advice or medical advice.
Sources
- Monash IVF ASX announcement — independent review completed, 20 August 2025
- Monash IVF ASX announcement — Brisbane incident, 10 April 2025
- Monash IVF ASX announcement — Clayton incident, 10 June 2025
- Monash IVF ASX announcement — Michael Knaap resignation notice, 24 June 2025
- Victorian Health Regulator — statement on Monash IVF Group
- Monash IVF FY24 annual report — class-action settlement
- Supreme Court of Victoria — Monash IVF group proceeding
- Health Records Act 2001 (Vic)
- Limitation of Actions Act 1958 (Vic)